Search
Descriptor English: Daclizumab
Descriptor Spanish: Daclizumab
Descriptor daclizumab
Entry term(s) Dacliximab
Ro 24 7375
Ro 24-7375
Ro 247375
Ro-24-7375
Zenapax
Zinbryta
Scope note: Anticuerpo monoclonal humanizado anti-TAC (SUBUNIDAD ALFA DEL RECEPTOR DE INTERLEUCINA-2) (inmunoglobulina G1, disulfuro con la cadena ligera del clon monoclonal humano-murino 1H4, dímero) que se usa en el tratamiento de la ESCLEROSIS MÚLTIPLE AGUDA RECURRENTE.
Descriptor Portuguese: Daclizumabe
Descriptor French: Daclizumab
Entry term(s): Dacliximab
Ro 24 7375
Ro 24-7375
Ro 247375
Ro-24-7375
Zenapax
Zinbryta
Tree number(s): D12.776.124.486.485.114.224.060.766
D12.776.124.790.651.114.224.060.766
D12.776.377.715.548.114.224.200.766
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077561
Scope note: An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
DE drug effects
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Pharm Action: Immunosuppressive Agents
Registry Number: CUJ2MVI71Y
Public MeSH Note: 2019; DACLIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2018; and under ANTIBODIES, MONOCLONAL 1995-2011
History Note: 2019 (1995)
DeCS ID: 57686
Unique ID: D000077561
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Daclizumab - Preferred
Concept UI M0252703
Scope note An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.
Preferred term Daclizumab
Entry term(s) Dacliximab
Zinbryta - Narrower
Concept UI M000622365
Preferred term Zinbryta
Zenapax - Narrower
Concept UI M0252702
Preferred term Zenapax
Ro 24-7375 - Narrower
Concept UI M0252700
Preferred term Ro 24-7375
Entry term(s) Ro 24 7375
Ro 247375
Ro-24-7375



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey